A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A

Hepatology

Volumn 42, Issue 1, 2005, Pages 72-76

  Höhler, Thomas ^a,c   Reuss, Esther ^a   Freitag, Christine M ^b   Schneider, Peter M ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c PROSPER HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10;

ADULT; AGE; ALLELE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BODY MASS; CYTOKINE PRODUCTION; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HEPATITIS A; HEPATITIS B; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OPEN STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SMOKING; VACCINATION; VIRUS HEPATITIS;

ADULT; ANTIGENS, VIRAL; FEMALE; HEPATITIS A VACCINES; HEPATITIS B SURFACE ANTIGENS; HUMANS; INTERLEUKIN-10; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; TWINS;

EID: 21344433222     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20740     Document Type: Article

References (22)

1. Hohler T, Reuss E, Evers N, Dietrich E, Rittner C, Freitag CM, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002;360:991-995.
2. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994;56:1-26.
3. Florentine DF, Zlotnik A, Mosmann TR, Howard M, O'Garta A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22.
4. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993;151:6853-61.
5. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 1992;89:1890-1893.
6. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998;95:9465-9470.
7. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors-a twin study. Genes Immun 2002;3:407-413.
8. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics 1996;45:82-83.
9. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line data-bases. Genes Immun 1999;1:3-19.
10. Kaluza W, Leirisalo-Repo M, Marker-Hermann E, Westman P, Reuss E, Hug R, et al. IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. Arthritis Rheum 2001;44:1209-1214.
11. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997;49:635-639.
12. Inc. SI. SAS/STAT Software: Changes and Enhancements through Release 6.12. SAS Institute Inc., 1997.
13. Jepson A, Banya W, Sisay-Joof F, Hassan-King M, Nunes C, Bennett S, et al. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens. Infection and Immunity 1997;65:872-876.
14. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003;98:144-50.
15. Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. HEPATOLOGY 2001;33:708-712.
16. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to Interferon alfa. HEPATOLOGY 1999;30: 526-350.
17. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002;97:2086-2092.
18. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101-1108.
19. Kurreeman FA, Schonkeren JJ, Heijmans BT, Toes RE, Huizinga TW. Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level. Hum Mol Genet 2004;13:1755-1762.
20. Rahman F, Dahmen A, Herzog-Hauff S, Bocher WO, Galle PR, Lohr HF. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. HEPATOLOGY 2000;31:521-527.
21. Bocher WO, Herzog-Hauff S, Schlaak J, Meyer zum Buschenfeld KH, Lohr HF. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. HEPATOLOGY 1999;29:238-244.
22. Hayney MS, Buck JM, Muller D. Production of interferon-gamma and interleukin-10 after inactivated hepatitis A immunization. Pharmacotherapy 2003;23:431-435.